The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model

Fluoxetine (FLX) is one of the selective serotonin reuptake inhibitors (SSRIs) antidepressants, which could be used to relieve depression and anxiety among AD patients. This study was designed to search for new mechanisms by which fluoxetine could activate Wnt/β-catenin signaling pathway and reduce...

Full description

Bibliographic Details
Main Authors: Min Huang, Yubin Liang, Hongda Chen, Binchu Xu, Cuicui Chai, Pengfei Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2018.00164/full
id doaj-eec433d5b6ee4186b8264997c9fff8e6
record_format Article
spelling doaj-eec433d5b6ee4186b8264997c9fff8e62020-11-24T22:57:29ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652018-06-011010.3389/fnagi.2018.00164347429The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse ModelMin Huang0Yubin Liang1Hongda Chen2Binchu Xu3Cuicui Chai4Pengfei Xing5Department of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, ChinaDepartment of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou, ChinaDepartment of Traditional Chinese Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, ChinaDepartment of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, ChinaDepartment of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, ChinaDepartment of Neurology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, ChinaFluoxetine (FLX) is one of the selective serotonin reuptake inhibitors (SSRIs) antidepressants, which could be used to relieve depression and anxiety among AD patients. This study was designed to search for new mechanisms by which fluoxetine could activate Wnt/β-catenin signaling pathway and reduce amyloidosis in AD brain. Fluoxetine was administered via intragastric injection to APP/tau/PS1 mouse model of Alzheimer’s disease (3×Tg-AD) mice for 4 months. In the hippocampus of AD mouse model, there could be observed neuronal apoptosis, as well as an increase in Aβ (amyloid-β) production. Moreover, there is a strong association between down-regulation of Wnt/β-catenin signaling and the alteration of AD pathology. The activity of protein phosphatases of type 2A (PP2A) could be significantly enhanced by the treatment of fluoxetine. The activation of PP2A, caused by fluoxetine, could then play a positive role in raising the level of active β-catenin, and deliver a negative impact in GSK3β activity in the hippocampal tissue. Both the changes mentioned above would lead to the activation of Wnt/β-catenin signaling. Meanwhile, fluoxetine treatment would reduce APP cleavage and Aβ generation. It could also prevent apoptosis in 3×Tg-AD primary neuronal cell, and have protective effects on neuron synapse. These findings imply that Wnt/β-catenin signaling could be a potential target outcome for AD prevention, and fluoxetine has the potential to be a promising drug in both AD prevention and treatment.https://www.frontiersin.org/article/10.3389/fnagi.2018.00164/fullfluoxetineAlzheimer’s diseaseWnt/β-catenin signalingprotein phosphatases of type 2A (PP2A)amyloid-β
collection DOAJ
language English
format Article
sources DOAJ
author Min Huang
Yubin Liang
Hongda Chen
Binchu Xu
Cuicui Chai
Pengfei Xing
spellingShingle Min Huang
Yubin Liang
Hongda Chen
Binchu Xu
Cuicui Chai
Pengfei Xing
The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
Frontiers in Aging Neuroscience
fluoxetine
Alzheimer’s disease
Wnt/β-catenin signaling
protein phosphatases of type 2A (PP2A)
amyloid-β
author_facet Min Huang
Yubin Liang
Hongda Chen
Binchu Xu
Cuicui Chai
Pengfei Xing
author_sort Min Huang
title The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
title_short The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
title_full The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
title_fullStr The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
title_full_unstemmed The Role of Fluoxetine in Activating Wnt/β-Catenin Signaling and Repressing β-Amyloid Production in an Alzheimer Mouse Model
title_sort role of fluoxetine in activating wnt/β-catenin signaling and repressing β-amyloid production in an alzheimer mouse model
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2018-06-01
description Fluoxetine (FLX) is one of the selective serotonin reuptake inhibitors (SSRIs) antidepressants, which could be used to relieve depression and anxiety among AD patients. This study was designed to search for new mechanisms by which fluoxetine could activate Wnt/β-catenin signaling pathway and reduce amyloidosis in AD brain. Fluoxetine was administered via intragastric injection to APP/tau/PS1 mouse model of Alzheimer’s disease (3×Tg-AD) mice for 4 months. In the hippocampus of AD mouse model, there could be observed neuronal apoptosis, as well as an increase in Aβ (amyloid-β) production. Moreover, there is a strong association between down-regulation of Wnt/β-catenin signaling and the alteration of AD pathology. The activity of protein phosphatases of type 2A (PP2A) could be significantly enhanced by the treatment of fluoxetine. The activation of PP2A, caused by fluoxetine, could then play a positive role in raising the level of active β-catenin, and deliver a negative impact in GSK3β activity in the hippocampal tissue. Both the changes mentioned above would lead to the activation of Wnt/β-catenin signaling. Meanwhile, fluoxetine treatment would reduce APP cleavage and Aβ generation. It could also prevent apoptosis in 3×Tg-AD primary neuronal cell, and have protective effects on neuron synapse. These findings imply that Wnt/β-catenin signaling could be a potential target outcome for AD prevention, and fluoxetine has the potential to be a promising drug in both AD prevention and treatment.
topic fluoxetine
Alzheimer’s disease
Wnt/β-catenin signaling
protein phosphatases of type 2A (PP2A)
amyloid-β
url https://www.frontiersin.org/article/10.3389/fnagi.2018.00164/full
work_keys_str_mv AT minhuang theroleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT yubinliang theroleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT hongdachen theroleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT binchuxu theroleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT cuicuichai theroleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT pengfeixing theroleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT minhuang roleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT yubinliang roleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT hongdachen roleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT binchuxu roleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT cuicuichai roleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
AT pengfeixing roleoffluoxetineinactivatingwntbcateninsignalingandrepressingbamyloidproductioninanalzheimermousemodel
_version_ 1725650600499085312